GNU social JP
  • FAQ
  • Login
GNU social JPは日本のGNU socialサーバーです。
Usage/ToS/admin/test/Pleroma FE
  • Public

    • Public
    • Network
    • Groups
    • Featured
    • Popular
    • People

Conversation

Notices

  1. Embed this notice
    Chuck Darwin (cdarwin@c.im)'s status on Saturday, 13-Dec-2025 03:46:28 JST Chuck Darwin Chuck Darwin

    The Food and Drug Administration rarely uses its authority to pull dangerous medical devices off the market
    and is so poorly staffed that it’s sometimes unable to make sure companies are taking critical steps to protect patients during health emergencies,
    according to a new report by the Government Accountability Office.

    The inquiry by the congressional watchdog was requested nearly two years ago by top members of the Senate
    in the wake of an investigation about the 2021 recall of breathing machines that threatened the health of millions of Americans.

    ProPublica and the Pittsburgh Post-Gazette revealed that the FDA had received hundreds of complaints over many years about the machines
    and never ordered a recall.

    Philips Respironics eventually recalled the devices, which were fitted with an industrial foam that could break down and release toxic material into the lungs of patients, including the elderly, veterans and infants.

    Philips had fielded thousands more complaints before initiating a recall and didn’t notify FDA, the news organizations found.

    Customers who relied on the continuous positive airway pressure, or CPAP, machines and other devices reported respiratory illnesses,
    kidney and liver conditions, and cancer.

    In 2023, U.S. Sens. Dick Durbin, D-Ill., and Richard Blumenthal, D-Conn., urged the GAO to investigate the agency’s practices
    amid one of the most tumultuous medical device recalls in recent history.

    In a statement, Durbin called the GAO report “long overdue,”
    saying it details
    “the harms caused by drastic staffing cuts”
    and “how weakened enforcement authority has made it even more difficult for FDA to carry out critical oversight activities.”

    The probe, which began last year, found the FDA doesn’t use its authority to force manufacturers to pull defective devices from the market.

    The agency has been empowered under federal law for decades to take such action,
    🔥but it has only done so four times, the last in 1992.

    In the vast number of cases, device makers voluntarily initiated recalls
    — about 900 in each of the past five years, the GAO said.

    https://www.propublica.org/article/fda-defective-device-recalls-gao-report

    In conversation about a month ago from c.im permalink

    Attachments

    1. Domain not in remote thumbnail source whitelist: daaz.com
      1992.in Domain Name Is Available to Buy - Domain Name Marketplace
      DaaZ, largest domain marketplace simple, easy & secure platform to buy domain names. Buy this 1992.in Domain at best price at DaaZ.

    2. No result found on File_thumbnail lookup.
      cancer.in - このウェブサイトは販売用です! - Cancer リソースおよび情報
      このウェブサイトは販売用です! cancer.in は、あなたがお探しの情報の全ての最新かつ最適なソースです。一般トピックからここから検索できる内容は、cancer.inが全てとなります。あなたがお探しの内容が見つかることを願っています!

    Feeds

    • Activity Streams
    • RSS 2.0
    • Atom
    • Help
    • About
    • FAQ
    • TOS
    • Privacy
    • Source
    • Version
    • Contact

    GNU social JP is a social network, courtesy of GNU social JP管理人. It runs on GNU social, version 2.0.2-dev, available under the GNU Affero General Public License.

    Creative Commons Attribution 3.0 All GNU social JP content and data are available under the Creative Commons Attribution 3.0 license.